Jun Li

Liaoning Technical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

1h-index1citations29works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Degradation and Inhibitors(15), Microtubule and mitosis dynamics(12), Multiple Myeloma Research and Treatments(9), Acute Myeloid Leukemia Research(5), PI3K/AKT/mTOR signaling in cancer(5)

Publications29 total

Process design and techno-economic evaluation of hydrogen production from microalgae conversion in molten salts

Journal of Cleaner Production·2026

Investigation on sealing efficiency and unsteady flow characteristics in a 1.5 stage axial turbine under thermal-fluid-solid interaction

Aerospace Science and Technology·2026

Figure S7 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Table S5 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Figure S2 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Table S1 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Table S13 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation·2026

Development of an active loading strategy for methylene blue in liposomes and its application in EGFR-targeted photodynamic therapy

Journal of Pharmaceutical Sciences·2026

Table S4 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Figure S3 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

High value-added utilization of coal gangue power generation slag for novel alkali-activated binders: mechanical and durability evaluation, and environmental impact

Chemical Engineering Journal·2026

Table S11 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Figure S6 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Multi-task vision image restoration by diffusion model with low-rank adaption for vibration displacement measurement

Journal of Sound and Vibration·2026

Table S2 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Figure S4 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Table S9 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Table S12 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

Table S10 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026Open Access

page 1 of 2Next →

Frequent Co-authors

W. Frank Lenoir(20), Michael R. McKeown(20), Wayne L. Glore(20), Yaretzi Calderón(20), Jessica Encinas(20), Luis A. Carvajal(20), Hua Gao(20), Nikolaus D. Obholzer(20), Minyun Zhou(20), Benjamin W. Trotter(20), Nikhil C. Munshi(20), Charles Y. Lin(20), Mariateresa Fulciniti(20), Peter B. Rahl(20), Zhihua Ma(19), Christopher J. Dinsmore(19), Yupeng Zheng(19), Michelle G. Shum(18), Giulia Giorgetti(17), Kameron R. Mori(17)